- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01137617
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients. (SCS)
The purpose of this study is to better understand how the Spinal Cord Stimulator works in relieving chronic pain.
The investigators are asking subject to take part in this study because who are chronic pain patients who already have a Spinal Cord Stimulator (SCS) in place.
The investigators hypothesize that chronic pain patients will have higher heat pain threshold and heat pain tolerance over the painful areas with the SCS on.
QST (Quantitative Sensory Testing, a heat/cold simulation test) might be an objective helpful tool for prudent patient selection for an expensive and invasive procedure for future SCS placement.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Sixty subjects who already have an implanted SCS device for pain management at the MGH Center for Pain Medicine and other Partners affiliated pain centers will be enrolled.
Inclusion Criteria:
- Subject is 18 years or older.
- Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.
Exclusion Criteria:
- Subject has neurological disease or a condition causing sensory deficit to the painful area.
- Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
- Subjects who are unable to travel to the study center.
It will be a one time outpatient visit study, which will include the following:
Brief pain history and Neurological examination
- Medical History (including medication use);
- Pain location, intensity, character and if known, etiology, duration;
- Maps of pain locations and paresthesia locations;
- Sensory neurological examination (e.g., alcohol swab, cotton swab, pinprick and vibration);
- A check on routine vital signs (blood pressure, pulse, pulse oximetry).
QST will include the following:
- Warm sensation, heat pain threshold, heat pain tolerance and wind-up. A cut-off of 53°C for heat will be preset to avoid tissue damage.
- QST will be done on two areas; painful area and non-painful area without paresthesia with the SCS turned off.
- Subject will then turn on SCS and a repeat QST will be performed on the painful and non-painful areas.
- QST tests will be performed in a quiet room at temperature 25º 2° C. The time and duration of the QST tests will be recorded.
QST will be performed at least 4 hours and no later than 6 hours after the last dose of long acting opioid and after last SCS on time. In this way the investigators will try to avoid recording possible end dose withdrawal and provide sufficient time for the subject to return to baseline for their SCS therapy.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02114
- MGH Center for Translational Pain Research
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Subject is 18 years or older.
- Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.
Exclusion Criteria:
- Subject has neurological disease or a condition causing sensory deficit to the painful area.
- Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.
- Subjects who are unable to travel to the study center.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Case-Alleen
- Tijdsperspectieven: Dwarsdoorsnede
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Warm Sensation (WS) Threshold- Pain Site
Tijdsspanne: WS threshold is assessed once at Visit 1
|
WS threshold is a type of Quantitative Sensory Test (QST).
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop stimulation when they first perceived a warm sensation.
Subjects performed this test with their SCS off and again with their SCS on.
|
WS threshold is assessed once at Visit 1
|
Heat Pain (HP) Threshold- Pain Site
Tijdsspanne: HP threshold is assessed once at Visit 1
|
Heat Pain threshold is a type of QST.
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop the stimulation when pain was first detected.
Subjects performed this test with their SCS off and again with their SCS on.
|
HP threshold is assessed once at Visit 1
|
Heat Pain Tolerance- Pain Site
Tijdsspanne: Heat Pain Tolerance is assessed once at Visit 1
|
Heat Pain threshold is a type of QST.
A contact thermode was attached to the subject's painful area that has SCS coverage.
The thermode increased by 1°C/sec from a baseline of 32°C.
Subjects were instructed to stop the stimulation when pain was no longer tolerable.
Subjects performed this test with their SCS off and again with their SCS on.
|
Heat Pain Tolerance is assessed once at Visit 1
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Shihab Ahmed, MD, Massachusetts General Hospital
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2010P 000425
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .